RANDALL KENNETH EDWARD purchased 26.1% of their position (20.80K shares) of TC BIOPHARM (HOLDINGS) PLC on the open market
Open‑market purchase worth $23.9K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/14/2022ACC: 0001929926-22-000002
10% Owner
Since Feb 2022
+20.80K
Net shares
Net buyer
$23.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20.80K acquired
Non-Derivative Transactions1
Ordinary Shares [ADS]
Direct
Shares
+20.80K
Price / share
$1.15
Trade value
$23.92K
% of position
26.1%
5/24/2022
79.61K→100.42K
Total
Net shares
+20.80K
Net value
$23.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares [ADS] Direct | 5/24/2022 | P · Purchase | +20.80K | $1.15 | $23.92K | 26.1% | 79.61K | 100.42K |
| Total | +20.80K | $23.92K | ||||||
Derivative Transactions0
No derivative transactions reported